GSA Capital Partners’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Buy
84,020
+51,798
+161% +$204K 0.02% 1362
2025
Q4
$131K Buy
+32,222
New +$144K 0.01% 1501
2025
Q3
Sell
-102,458
Closed -$280K 2043
2025
Q2
$280K Buy
+102,458
New +$211K 0.02% 1301
2024
Q3
Sell
-184,728
Closed -$1.01M 1964
2024
Q2
$1.01M Buy
184,728
+148,520
+410% +$1.18M 0.07% 495
2024
Q1
$362K Sell
36,208
-132,763
-79% -$995K 0.03% 1097
2023
Q4
$689K Sell
168,971
-371,279
-69% -$1.37M 0.06% 598
2023
Q3
$2.09M Buy
+540,250
New +$2.9M 0.18% 100
2023
Q2
Sell
-265,372
Closed -$868K 1894
2023
Q1
$868K Sell
265,372
-62,421
-19% -$249K 0.09% 396
2022
Q4
$1.29M Buy
327,793
+130,816
+66% +$640K 0.16% 104
2022
Q3
$1.18M Buy
196,977
+101,667
+107% +$734K 0.16% 102
2022
Q2
$613K Sell
95,310
-40,795
-30% -$260K 0.09% 375
2022
Q1
$1.12M Buy
+136,105
New +$1.1M 0.15% 138

Other funds holding SANA